Cargando…

Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial

BACKGROUND: Older patients at risk of functional decline are frequently affected by polypharmacy. This is associated with a further loss of independence. However, a relationship between functional disability and medications, such as ‘Potentially Inappropriate Medications’ (PIMs) and ‘Potential Presc...

Descripción completa

Detalles Bibliográficos
Autores principales: Salm, Claudia, Sauer, Julia, Binder, Nadine, Pfefferle, Aline, Sofroniou, Mario, Metzner, Gloria, Farin-Glattacker, Erik, Voigt-Radloff, Sebastian, Maun, Andy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260981/
https://www.ncbi.nlm.nih.gov/pubmed/35799113
http://dx.doi.org/10.1186/s12877-022-03242-w
_version_ 1784742165172191232
author Salm, Claudia
Sauer, Julia
Binder, Nadine
Pfefferle, Aline
Sofroniou, Mario
Metzner, Gloria
Farin-Glattacker, Erik
Voigt-Radloff, Sebastian
Maun, Andy
author_facet Salm, Claudia
Sauer, Julia
Binder, Nadine
Pfefferle, Aline
Sofroniou, Mario
Metzner, Gloria
Farin-Glattacker, Erik
Voigt-Radloff, Sebastian
Maun, Andy
author_sort Salm, Claudia
collection PubMed
description BACKGROUND: Older patients at risk of functional decline are frequently affected by polypharmacy. This is associated with a further loss of independence. However, a relationship between functional disability and medications, such as ‘Potentially Inappropriate Medications’ (PIMs) and ‘Potential Prescribing Omissions’ (PPOs), as itemised for (de) prescribing in practice-orientated medication lists, has yet to be established. METHODS: As part of a randomised comparative effectiveness trial, LoChro, we conducted a cross-sectional analysis of the association between PIMs and PPOs measured using the ‘Screening Tool of Older Persons’ Prescription Criteria / Screening Tool To Alert to Right Treatment’ (STOPP/START) Version 2, with functional disability assessed using the ‘World Health Organization Disability Assessment Schedule 2.0’ (WHODAS). Individuals aged 65 and older at risk of loss of independence were recruited from the inpatient and outpatient departments of the local university hospital. Multiple linear regression analysis was used to model the potential prediction of functional disability using the numbers of PIMs and PPOs, adjusted for confounders including multimorbidity. RESULTS: Out of 461 patients, both the number of PIMs and the number of PPOs were significantly associated with an increase in WHODAS-score (Regression coefficients B 2.7 [95% confidence interval: 1.5-3.8] and 1.5 [95% confidence interval: 0.2-2.7], respectively). In WHODAS-score prediction modelling the contribution of the number of PIMs exceeded the one of multimorbidity (standardised coefficients beta: PIM 0.20; multimorbidity 0.13; PPO 0.10), whereas no significant association between the WHODAS-score and the number of medications was seen. 73.5 % (339) of the participants presented with at least one PIM, and 95.2% (439) with at least one PPO. The most common PIMs were proton pump inhibitors and analgesic medication, with frequent PPOs being pneumococcal and influenza vaccinations, as well as osteoporosis prophylaxis. CONCLUSIONS: The results indicate a relationship between inappropriate prescribing, both PIMs and PPOs, and functional disability, in older patients at risk of further decline. Long-term analysis may help clarify whether these patients benefit from interventions to reduce PIMs and PPOs.
format Online
Article
Text
id pubmed-9260981
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92609812022-07-08 Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial Salm, Claudia Sauer, Julia Binder, Nadine Pfefferle, Aline Sofroniou, Mario Metzner, Gloria Farin-Glattacker, Erik Voigt-Radloff, Sebastian Maun, Andy BMC Geriatr Research BACKGROUND: Older patients at risk of functional decline are frequently affected by polypharmacy. This is associated with a further loss of independence. However, a relationship between functional disability and medications, such as ‘Potentially Inappropriate Medications’ (PIMs) and ‘Potential Prescribing Omissions’ (PPOs), as itemised for (de) prescribing in practice-orientated medication lists, has yet to be established. METHODS: As part of a randomised comparative effectiveness trial, LoChro, we conducted a cross-sectional analysis of the association between PIMs and PPOs measured using the ‘Screening Tool of Older Persons’ Prescription Criteria / Screening Tool To Alert to Right Treatment’ (STOPP/START) Version 2, with functional disability assessed using the ‘World Health Organization Disability Assessment Schedule 2.0’ (WHODAS). Individuals aged 65 and older at risk of loss of independence were recruited from the inpatient and outpatient departments of the local university hospital. Multiple linear regression analysis was used to model the potential prediction of functional disability using the numbers of PIMs and PPOs, adjusted for confounders including multimorbidity. RESULTS: Out of 461 patients, both the number of PIMs and the number of PPOs were significantly associated with an increase in WHODAS-score (Regression coefficients B 2.7 [95% confidence interval: 1.5-3.8] and 1.5 [95% confidence interval: 0.2-2.7], respectively). In WHODAS-score prediction modelling the contribution of the number of PIMs exceeded the one of multimorbidity (standardised coefficients beta: PIM 0.20; multimorbidity 0.13; PPO 0.10), whereas no significant association between the WHODAS-score and the number of medications was seen. 73.5 % (339) of the participants presented with at least one PIM, and 95.2% (439) with at least one PPO. The most common PIMs were proton pump inhibitors and analgesic medication, with frequent PPOs being pneumococcal and influenza vaccinations, as well as osteoporosis prophylaxis. CONCLUSIONS: The results indicate a relationship between inappropriate prescribing, both PIMs and PPOs, and functional disability, in older patients at risk of further decline. Long-term analysis may help clarify whether these patients benefit from interventions to reduce PIMs and PPOs. BioMed Central 2022-07-07 /pmc/articles/PMC9260981/ /pubmed/35799113 http://dx.doi.org/10.1186/s12877-022-03242-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Salm, Claudia
Sauer, Julia
Binder, Nadine
Pfefferle, Aline
Sofroniou, Mario
Metzner, Gloria
Farin-Glattacker, Erik
Voigt-Radloff, Sebastian
Maun, Andy
Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
title Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
title_full Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
title_fullStr Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
title_full_unstemmed Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
title_short Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
title_sort over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260981/
https://www.ncbi.nlm.nih.gov/pubmed/35799113
http://dx.doi.org/10.1186/s12877-022-03242-w
work_keys_str_mv AT salmclaudia overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT sauerjulia overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT bindernadine overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT pfefferlealine overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT sofronioumario overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT metznergloria overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT faringlattackererik overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT voigtradloffsebastian overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial
AT maunandy overandunderprescribingandtheirassociationwithfunctionaldisabilityinolderpatientsatriskoffurtherdeclineingermanyacrosssectionalsurveyconductedaspartofarandomisedcomparativeeffectivenesstrial